Improving survival with deferiprone treatment in patients with thalassemia major: A prospective multicenter randomised clinical trial under the auspices of the Italian Society for Thalassemia and Hemoglobinopathies

Blood Cells, Molecules, and Diseases

Volumn 42, Issue 3, 2009, Pages 247-251

  Maggio, Aurelio ^a   Vitrano, Angela ^a   Capra, Marcello ^b   Cuccia, Liana ^b   Gagliardotto, Francesco ^b   Filosa, Aldo ^c   Magnano, Carmelo ^d   Rizzo, Michele ^e   Caruso, Vincenzo ^d   Gerardi, Calogera ^f   Argento, Crocetta ^g   Campisi, Saveria ^h   Cantella, Francesco ⁱ   Commendatore, Francesca ^j   D'Ascola, Domenico Giuseppe ^k   Fidone, Carmelo ^l   Ciancio, Angela ^m   Galati, Maria Concetta ⁿ   Giuffrida, Gaetano ^o   Cingari, Rocca ^o   Giugno, Giovanni ^f   Lombardo, Turi ^p   Prossomariti, Luciano ^q   Malizia, Roberto ^r   Meo, Anna ^s   Roccamo, Gaetano ^t   Romeo, Maria Antonietta ^u   Violi, Pietro ^v   Cianciulli, Paolo ^w   Rigano, Paolo ^a   more..

^a UOC Ematologia II con Talassemia   (Italy)

^b Centro di Prevenzione Diagnosi e Cura della Talassemia   (Italy)

^c UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^d Unità Operativa Dipartimentale Talassemia   (Italy)

^e UOC Ematologia   (Italy)

^f AOOCR ^*  (Italy)

^g AO S Giovanni di Dio   (Italy)

^h UOS Centro Microcitemia   (Italy)

ⁱ UOC Medicina Trasfusionale   (Italy)

^j ASL 8 Siracusa   (Italy)

^k Centro Microcitemia   (Italy)

^l U O C Centro Trasfusionale   (Italy)

^m MADONNA DELLE GRAZIE HOSPITAL   (Italy)

ⁿ Dipartimento Ematologia   (Italy)

^o AO Ferrarotto   (Italy)

^p UOC di Ematologia con Talassemia   (Italy)

^q Centro Regionale per la Cura delle Microcitemie   (Italy)

^r UOC Pediatria   (Italy)

^s UNIVERSITY OF MESSINA   (Italy)

^t Centro Microcitemia   (Italy)

^u UNIVERSITY OF CATANIA   (Italy)

^v CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

^w AO S Eugenio   (Italy)

more..

Author keywords

chelation treatment; thalassemia major; thalassemia survival; thalassemia trial

Indexed keywords

DEFERIPRONE; DEFEROXAMINE; FERRITIN;

ADOLESCENT; ADULT; AGE; ARTICLE; BLOOD TRANSFUSION; BONE MARROW TRANSPLANTATION; CAUSE OF DEATH; CHELATION THERAPY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETES MELLITUS; DRUG DOSE SEQUENCE; DRUG WITHDRAWAL; EVENING DOSAGE; FEMALE; FERRITIN BLOOD LEVEL; FOLLOW UP; GRAFT VERSUS HOST REACTION; HAZARD RATIO; HEART ARRHYTHMIA; HEART FAILURE; HUMAN; HYPOGONADISM; HYPOTHYROIDISM; IRON CHELATION; IRON OVERLOAD; ITALY; LIVER CIRRHOSIS; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OPEN STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK FACTOR; SEX DIFFERENCE; SURVIVAL; THALASSEMIA MAJOR;

ADOLESCENT; ADULT; BETA-THALASSEMIA; BLOOD TRANSFUSION; CAUSE OF DEATH; CHELATION THERAPY; CHILD; COMBINED MODALITY THERAPY; DEFEROXAMINE; DRUG THERAPY, COMBINATION; FEMALE; HEART FAILURE; HUMANS; IRON CHELATING AGENTS; KAPLAN-MEIERS ESTIMATE; MALE; MIDDLE AGED; NEOPLASMS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; PYRIDONES; SPLENECTOMY; SURVIVAL RATE; YOUNG ADULT;

EID: 64849100325     PISSN: 10799796     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcmd.2009.01.002     Document Type: Article

References (16)

1. Modell B., and Berdoukas V. The Clinical Approach to Thalassaemia (1984), Grune and Stratton, New York and London
2. Hussain M.A.M., Flynn D.M., Green N., et al. Sub-cutaneous infusion and intramuscular injection of desferrioxamine in patients with transfusional iron overload. Lancet ii (1976) 1278-1283
3. Borgna-Pignatti C., Rugolotto S., De Stefano P., et al. Survival and complications in patients with thalassemia major treated with transfusion and deferoxamine. Haematologica 89 (2004) 1187-1193
4. Borgna-Pignatti C., Cappellini M.C., De Stefano P., Del Vecchio G.C., et al. Cardiac morbidity and mortality in deferoxamine or deferiprone-treated patients with thalassemia major. Blood 107 (2006) 3733-3737
5. Maggio A., D'Amico G., Morabito A., et al. Deferiprone versus deferoxamine in patients with thalassemia major: a randomized clinical trial. Blood Cells Mol. and Dis. 28 2 (2002) 196-208
6. Piga A., Gaglioti G., Fogliacco E., and Tricta F. Comparative effects of deferiprone and deferoxamine on survival and cardiac disease in patients with thalassaemia major: a retrospective analysis. Haematologica 88 (2003) 489-496
7. Ceci A., Baiardi P., Catapano M., et al. Risk factors for death in patients with β-thalassemia major: results of a case-control study. Haematologica 91 10 (2005) 1420-1421
8. Telfer P., Coen P.C., Christou S., et al. Survival of medically treated thalassemia patients in Cyprus. Trends and risk factors over the period 1980-2004. Haematologica 91 (2006) 1187-1192
9. Tanner M.A., Galanello R., Dessi C., et al. Combined chelation therapy in thalassemia major for the treatment of severe myocardial siderosis with left ventricular dysfunction. J. of Card. Magn. Res. 10 (2008) 12
10. Modell B., Khan M., Darlison M., et al. Improved survival of thalassaemia major in the UK and relation to T2* cardiovascular magnetic resonance. J. of Card. Magn. Res. 10 (2008) 42
11. Vittinghoff E., Shiboski S.C., Glidden D.V., and McCulloch C.E. Regression Methods in Biostatistics. Linear, Logistic, Survival and Repeated Measures Models (2005), Springer Science+Business Media, Inc., 233 Spring Street, New York, NY 10013, USA
12. Collett D. 1952-Modelling Survival Data in Medical Research. Second Edition. (2003), Chapman and Hall/CRC CRC Press LLC
13. World Medical Association. Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects, http://www.wma.net/e/policy/b3.htm.
14. Tiziana C., Derchi G., Mancuso L., et al. Under the auspices of the Society for the Study of Thalassemia and Haemoglobinopathies (SoSTE). Guideline recommendations for heart complications in thalassemia major. J. of Card. Med. 9 (2008) 515-525
15. Olivieri N.F., Nathan D.G., McMillan J.H., et al. Survival in medically treated patients with homozygous beta-thalassaemia. New Engl. J. of Med. 331 9 (1994) 574-578
16. Mathers C.D., Sadana R., Salomon J.A., et al. Healthy life expectancy in 191 countries. 1999, Lancet 357 (2001) 1685-1691